Tudor Investment Corp
RVNC

Tudor Investment Corp’s Revance Therapeutics, Inc. RVNC Stock Holding History

Tudor Investment Corp’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-72,579
Closed -$377K – 3609
2024
Q3 		$377K Buy
72,579
+29,360
+68% +$146K ﹤0.01% 2184
2024
Q2 		$111K Buy
43,219
+10,878
+34% +$37.1K ﹤0.01% 2199
2024
Q1 		$159K Buy
+32,341
New +$191K ﹤0.01% 2067
2023
Q2 		– Sell
-19,719
Closed -$635K – 3025
2023
Q1 		$635K Sell
19,719
-21,357
-52% -$666K 0.01% 1477
2022
Q4 		$758K Buy
+41,076
New +$940K 0.02% 1311
2022
Q3 		– Sell
-74,119
Closed -$1.02M – 2793
2022
Q2 		$1.02M Sell
74,119
-15,453
-17% -$238K 0.03% 872
2022
Q1 		$1.75M Buy
+89,572
New +$1.36M 0.04% 620
2021
Q3 		– Sell
-64,616
Closed -$1.92M – 2882
2021
Q2 		$1.92M Buy
+64,616
New +$1.86M 0.04% 582
2016
Q3 		– Sell
-27,200
Closed -$370K – 1785
2016
Q2 		$370K Buy
+27,200
New +$481K 0.01% 1037
2016
Q1 		– Sell
-11,000
Closed -$376K – 2015
2015
Q4 		$376K Buy
+11,000
New +$381K 0.01% 1091

Other funds holding RVNC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Tudor Investment Corp's RVNC Position: Q4 2024 in Review

Tudor Investment Corp sold out of Revance Therapeutics, Inc. (RVNC) in Q4 2024, closing a stake of 72,579 shares — an estimated $377K sold.

Tudor Investment Corp first reported a position in RVNC in Q4 2015 and held it in 10 quarters. The position peaked at $1.92M in Q2 2021. 173 funds tracked by Wall St. Rank hold RVNC as of Q4 2024.

  • Tudor Investment Corp reported no remaining Revance Therapeutics, Inc. position as of Q4 2024 after selling out during the quarter.
  • Tudor Investment Corp sold 72,579 Revance Therapeutics, Inc. shares in Q4 2024, an estimated $377K.
  • Tudor Investment Corp first reported a position in Revance Therapeutics, Inc. in Q4 2015 and held it in 10 quarters.
  • Tudor Investment Corp's Revance Therapeutics, Inc. position peaked at $1.92M in Q2 2021.
  • 173 funds tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q4 2024.

Based on Tudor Investment Corp's 13F filing for Q4 2024, filed 14 Feb 2025.